Report : Home Diagnostics for Urinary Tract Infection Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Form Type (Dipsticks, Cup, Dipslide, Cassette, Others); Distribution Channel (Retail Pharmacies & Drug Store, Supermarket/Hypermarket, Online Pharmacies), and Geography
Dipsticks Segment by Form Type to Accelerate During Forecast Period
According to The Insight Partners market research study on “Home Diagnostic for Urinary Tract Infection Market to 2027 - Global Analysis and Forecast by Form Type and Distribution Channel,” the global home diagnostics for urinary tract infection market is expected to reach US$ 1,354.02 million by 2027 from US$ 847.85 million in 2019. It is estimated to grow at a CAGR of 6.2% from 2020 to 2027. The report provides trends prevailing in the global home diagnostics for urinary tract infection market and the factors driving the market growth along with those restraining it.
The growth of the home diagnostics for urinary tract infection market is attributed to the growing prevalence of urinary tract infections and increasing geriatric population. Based on form type, the global home diagnostics for urinary tract infection market is segmented into dipsticks, cup, dipslide, cassette, and others. The dipsticks segment held the largest share of the market in 2019, and it is estimated to register the highest CAGR in during the forecast period.
i-Health, Inc (AZO), F. Hoffmann-La Roche AG (Roche Holding AG), Acon Laboratories, Inc., Becton Dickinson and Company, Arkray Inc., BTNX Inc, Abbott Laboratories, Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc), Teco Diagnostics, and Atlas Medical are some of the leading companies operating in the home diagnostics for urinary tract infection market.
The report segments global home diagnostic for urinary tract infection market as follows: